SE8801537D0 - Cellodlingsmedium samt forfarande for dess framstellning - Google Patents

Cellodlingsmedium samt forfarande for dess framstellning

Info

Publication number
SE8801537D0
SE8801537D0 SE8801537A SE8801537A SE8801537D0 SE 8801537 D0 SE8801537 D0 SE 8801537D0 SE 8801537 A SE8801537 A SE 8801537A SE 8801537 A SE8801537 A SE 8801537A SE 8801537 D0 SE8801537 D0 SE 8801537D0
Authority
SE
Sweden
Prior art keywords
pct
platelets
lysate
cell culture
sec
Prior art date
Application number
SE8801537A
Other languages
English (en)
Inventor
O Holmqvist
Original Assignee
Ellco Food Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ellco Food Ab filed Critical Ellco Food Ab
Priority to SE8801537A priority Critical patent/SE8801537D0/sv
Publication of SE8801537D0 publication Critical patent/SE8801537D0/sv
Priority to AT89905220T priority patent/ATE107353T1/de
Priority to AU35392/89A priority patent/AU3539289A/en
Priority to US07/634,113 priority patent/US5198357A/en
Priority to DE68916244T priority patent/DE68916244T2/de
Priority to EP89905220A priority patent/EP0413727B1/en
Priority to JP1504957A priority patent/JPH03505156A/ja
Priority to PCT/SE1989/000232 priority patent/WO1989010398A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C12N5/163—Animal cells one of the fusion partners being a B or a T lymphocyte
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/70—Undefined extracts
    • C12N2500/80—Undefined extracts from animals
    • C12N2500/84—Undefined extracts from animals from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SE8801537A 1988-04-26 1988-04-26 Cellodlingsmedium samt forfarande for dess framstellning SE8801537D0 (sv)

Priority Applications (8)

Application Number Priority Date Filing Date Title
SE8801537A SE8801537D0 (sv) 1988-04-26 1988-04-26 Cellodlingsmedium samt forfarande for dess framstellning
AT89905220T ATE107353T1 (de) 1988-04-26 1989-04-26 Blutplättchenlysat, verfahren zu seiner herstellung sowie ein solches lysat enthaltendes zellkulturmedium.
AU35392/89A AU3539289A (en) 1988-04-26 1989-04-26 Blood platelet lysate, method of its preparation and a cell culture medium containing said blood platelet lysate
US07/634,113 US5198357A (en) 1988-04-26 1989-04-26 Preparation of a blood platelet lysate for use in a cell culture medium for hybridoma cells
DE68916244T DE68916244T2 (de) 1988-04-26 1989-04-26 Blutplättchenlysat, verfahren zu seiner herstellung sowie ein solches lysat enthaltendes zellkulturmedium.
EP89905220A EP0413727B1 (en) 1988-04-26 1989-04-26 Blood platelet lysate, method of its preparation and a cell culture medium containing said blood platelet lysate
JP1504957A JPH03505156A (ja) 1988-04-26 1989-04-26 血小板溶解産物、その調製法および該血小板溶解産物を含む細胞培養培地
PCT/SE1989/000232 WO1989010398A1 (en) 1988-04-26 1989-04-26 Blood platelet lysate, method of its preparation and a cell culture medium containing said blood platelet lysate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8801537A SE8801537D0 (sv) 1988-04-26 1988-04-26 Cellodlingsmedium samt forfarande for dess framstellning

Publications (1)

Publication Number Publication Date
SE8801537D0 true SE8801537D0 (sv) 1988-04-26

Family

ID=20372119

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8801537A SE8801537D0 (sv) 1988-04-26 1988-04-26 Cellodlingsmedium samt forfarande for dess framstellning

Country Status (8)

Country Link
US (1) US5198357A (sv)
EP (1) EP0413727B1 (sv)
JP (1) JPH03505156A (sv)
AT (1) ATE107353T1 (sv)
AU (1) AU3539289A (sv)
DE (1) DE68916244T2 (sv)
SE (1) SE8801537D0 (sv)
WO (1) WO1989010398A1 (sv)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5723443A (en) * 1988-02-02 1998-03-03 Hankyu-Kyoei Bussan Co. Ltd. Lipid metabolism promoting agent and its use
JPH04198129A (ja) * 1990-11-28 1992-07-17 Sumitomo Pharmaceut Co Ltd 活性型ビタミンｄ↓３類含有組成物
DE69809391T2 (de) * 1997-02-06 2003-07-10 Therasense, Inc. Kleinvolumiger sensor zur in-vitro bestimmung
JP3521382B2 (ja) * 1997-02-27 2004-04-19 日本たばこ産業株式会社 細胞間接着及びシグナル伝達を媒介する細胞表面分子
DE19821060A1 (de) 1997-09-23 1999-04-15 Bundesrepublik Deutschland Let Ko-stimulierendes Polypeptid von T-Zellen, monoklonale Antikörper sowie die Herstellung und deren Verwendung
DE59813875D1 (de) * 1997-09-23 2007-02-22 Bundesrepublik Deutschland Let Ko-stimulierendes polypeptid von t-zellen, monoklonale antikörper sowie die herstellung und deren verwendung
CA2562764A1 (en) 2004-04-23 2005-11-03 Richard Kroczek Method for the treatment of t cell mediated conditions by depletion of icos-positive cells in vivo
US20060039991A1 (en) * 2004-08-20 2006-02-23 Alberto Gorrochategui Barrueta Biological tissue regenerative agent and method for preparing and using same
US8632970B2 (en) 2005-05-09 2014-01-21 Affymetrix, Inc. Multiplex capture of nucleic acids
US8628918B2 (en) * 2005-05-09 2014-01-14 Affymetrix, Inc. Multiplex capture of nucleic acids
US7803541B2 (en) * 2005-05-12 2010-09-28 Panomics, Inc. Multiplex branched-chain DNA assays
EP3042963A1 (en) * 2005-06-20 2016-07-13 Advanced Cell Diagnostics, Inc. Methods of detecting nucleic acids in individual cells and of identifying rare cells from large heterogeneous cell populations
SE0501462L (sv) * 2005-06-23 2006-09-26 Proliff Ab Förfarande för framställning av blodplättslysat
US7927798B2 (en) * 2005-10-05 2011-04-19 Panomics, Inc. Detection of nucleic acids from whole blood
WO2007087519A2 (en) * 2006-01-24 2007-08-02 Centeno Christopher J Mesenchymal stem cell isolation and transplantation method and system to be used in a clinical setting
WO2008034803A1 (en) * 2006-09-18 2008-03-27 Medizinische Universität Graz Plasma-free platelet lysate for use as a supplement in cell cultures and for the preparation of cell therapeutics
US9095562B2 (en) 2007-07-05 2015-08-04 Regenerative Sciences, Inc. Methods and compositions for optimized expansion and implantation of mesenchymal stem cells
WO2009085969A2 (en) 2007-12-19 2009-07-09 Regenerative Sciences, Llc Compositions and methods to promote implantation and engrafment of stem cells
EP2257176B1 (en) 2008-03-14 2013-09-18 Regenerative Sciences, LLC Compositions and methods for cartilage repair
WO2010003057A2 (en) 2008-07-03 2010-01-07 Mayo Foundation For Medical Education And Research Treating cancer
FI3584310T3 (fi) 2008-09-16 2024-07-02 Mayo Found Medical Education & Res Verihiutaleiden sisältöä sisältäviä koostumuksia
AR074551A1 (es) 2008-12-05 2011-01-26 Regenerative Sciences Llc Metodos y composiciones para facilitar la reparacion de tejido avascular
US20100168022A1 (en) * 2008-12-11 2010-07-01 Centeno Christopher J Use of In-Vitro Culture to Design or Test Personalized Treatment Regimens
US20110054929A1 (en) * 2009-09-01 2011-03-03 Cell Solutions Colorado Llc Stem Cell Marketplace
HUP0900603A2 (en) * 2009-09-25 2012-02-28 Biomarker Kft Cell culture medium
US9113950B2 (en) 2009-11-04 2015-08-25 Regenerative Sciences, Llc Therapeutic delivery device
EP3034625B1 (en) 2010-10-21 2017-10-04 Advanced Cell Diagnostics, Inc. An ultra sensitive method for in situ detection of nucleic acids
US9427477B2 (en) 2011-05-09 2016-08-30 Mayo Foundation For Medical Education And Research Cancer treatments
WO2012158983A2 (en) 2011-05-17 2012-11-22 Qiyong Peter Liu Improved platelet storage using a sialidase inhibitor
US9788539B2 (en) 2011-05-17 2017-10-17 Velico Medical, Inc. Platelet protection solution having beta-galactosidase and sialidase inhibitors
EP2540819A1 (en) 2011-06-27 2013-01-02 Rheinisch-Westfälische Technische Hochschule Aachen (RWTH) Method for cultivating cells in platelet-lysate-containing medium
US9688959B2 (en) * 2011-06-27 2017-06-27 Emory University Compositions, uses, and preparation of platelet lysates
AU2012275335B2 (en) 2011-06-29 2017-04-20 Biorestorative Therapies, Inc. Brown fat cell compositions and methods
US10472609B2 (en) 2011-07-06 2019-11-12 Cell Therapy Limited Progenitor cells of mesodermal lineage
ITRM20110500A1 (it) * 2011-09-23 2013-03-24 Futura Stem Cells Sa Lisato piastrinico, usi di esso e metodo per la sua preparazione
WO2013076507A2 (en) 2011-11-23 2013-05-30 Cell Therapy Limited Platelet lysate gel
US10413606B2 (en) 2012-10-01 2019-09-17 Mayo Foundation For Medical Education And Research Methods for treating cancer with nanoparticle complexes of albumin-bound paclitaxel and anti-VEGF antibodies
WO2014055988A1 (en) 2012-10-05 2014-04-10 Velico Medical, Inc. Platelet additive solution having a beta-galactosidase inhibitor
EP2733200A1 (en) 2012-11-15 2014-05-21 Biorigen International SA Cell culture supplements
WO2014117140A1 (en) * 2013-01-28 2014-07-31 Regenerative Sciences, Llc Device and methods for platelet lysis or activation
WO2014120886A1 (en) 2013-01-30 2014-08-07 Velico Medical, Inc. Platelet additive solution having a self-assembling hydrogel-forming peptide
US10167449B2 (en) 2013-04-19 2019-01-01 Biorestorative Therapies, Inc. Human brown adipose derived stem cells and uses
MX2016002492A (es) * 2013-08-27 2016-12-09 Cook General Biotechnology Llc Composiciones bioactivas derivables de concentrados de plaquetas, y metodos para prepararlas y usarlas.
EP3143130B1 (en) 2014-05-16 2024-03-06 Mayo Foundation for Medical Education and Research Cell culture media compositions for primary cells
GB201410504D0 (en) 2014-06-12 2014-07-30 Cell Therapy Ltd Immuno-modulaltory progenitor (IMP) cell
KR20210125603A (ko) 2014-06-16 2021-10-18 메이오 파운데이션 포 메디칼 에쥬케이션 앤드 리써치 골수종의 치료
US9446148B2 (en) 2014-10-06 2016-09-20 Mayo Foundation For Medical Education And Research Carrier-antibody compositions and methods of making and using the same
GB201513996D0 (en) 2015-08-07 2015-09-23 Cell Therapy Ltd Immuno-oncology mesodermal progenitor (IOMP) cell
TW201707725A (zh) 2015-08-18 2017-03-01 美國馬友醫藥教育研究基金會 載體－抗體組合物及其製造及使用方法
KR20170037379A (ko) * 2015-09-25 2017-04-04 (주)프로스테믹스 세포의 증식 촉진용 조성물 및 이를 포함하는 세포 배양용 배지
TW201713360A (en) 2015-10-06 2017-04-16 Mayo Foundation Methods of treating cancer using compositions of antibodies and carrier proteins
DK3362462T3 (da) 2015-10-12 2021-10-11 Advanced Cell Diagnostics Inc In situ-detektion af nukleotidvarianter i prøver med højt støjniveau, og sammensætninger og fremgangsmåder relateret dertil
GB201518263D0 (en) 2015-10-15 2015-12-02 Oxford Bioelectronics Ltd Method
EP3399861A4 (en) 2016-01-07 2019-08-07 Mayo Foundation for Medical Education and Research INTERFERON CANCER TREATMENT METHODS
WO2017139698A1 (en) 2016-02-12 2017-08-17 Mayo Foundation For Medical Education And Research Hematologic cancer treatments
EP3432926A4 (en) 2016-03-21 2019-11-20 Mayo Foundation for Medical Education and Research METHODS OF REDUCING THE TOXICITY OF A CHEMOTHERAPEUTIC MEDICAMENT
EP3432928A4 (en) 2016-03-21 2019-11-20 Mayo Foundation for Medical Education and Research PROCESS FOR IMPROVING THE THERAPEUTIC INDEX FOR CHEMOTHERAPEUTIC
US10618969B2 (en) 2016-04-06 2020-04-14 Mayo Foundation For Medical Education And Research Carrier-binding agent compositions and methods of making and using the same
US20200325442A1 (en) 2016-06-02 2020-10-15 Pl Bioscience Gmbh Method for producing a platelet-lysate-containing gel
CA3035378A1 (en) 2016-09-01 2018-03-08 Mayo Foundation For Medical Education And Research Carrier-pd-l1 binding agent compositions for treating cancers
JP2019526579A (ja) 2016-09-01 2019-09-19 マヨ ファウンデーション フォー メディカル エデュケーション アンド リサーチＭａｙｏ Ｆｏｕｎｄａｔｉｏｎ Ｆｏｒ Ｍｅｄｉｃａｌ Ｅｄｕｃａｔｉｏｎ Ａｎｄ Ｒｅｓｅａｒｃｈ Ｔ細胞癌を標的とする為の方法及び組成物
KR102486055B1 (ko) 2016-09-06 2023-01-09 메이오 파운데이션 포 메디칼 에쥬케이션 앤드 리써치 파클리탁셀-알부민-결합제 조성물 및 그의 사용 및 제조 방법
KR20230011473A (ko) 2016-09-06 2023-01-20 메이오 파운데이션 포 메디칼 에쥬케이션 앤드 리써치 Ｐｄ－ｌ１ 발현 암의 치료 방법
EP3509635A1 (en) 2016-09-06 2019-07-17 Vavotar Life Sciences LLC Methods of treating triple-negative breast cancer using compositions of antibodies and carrier proteins
CN109468262A (zh) * 2018-10-30 2019-03-15 中国科学院苏州生物医学工程技术研究所 家畜血细胞制备动物细胞培养液的方法及其制得的动物细胞培养液的应用
WO2020148520A1 (en) 2019-01-15 2020-07-23 Cell Therapy Limited Mesodermal killer (mk) cell
GB201900554D0 (en) 2019-01-15 2019-03-06 Cell Therapy Ltd Mesodermal killer (mk) cell
CN110484497A (zh) * 2019-09-05 2019-11-22 中国人民解放军南部战区总医院 一种血小板裂解液及其制备方法和应用
US11951134B2 (en) 2019-09-30 2024-04-09 North Carolina State University Cationic platelet lysate compositions and related methods
CN116926001A (zh) * 2022-04-06 2023-10-24 上海我武干细胞科技有限公司 血清替代物及其制备方法与应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8000527A (nl) * 1980-01-29 1981-08-17 Stichting Vrienden Van De Stic Werkwijze voor het bevorderen van hybridisatie van cellen in vitro en van de produktie en uitscheiding van stoffen, gevormd door dergelijke celhybriden, werkwijze voor het bevorderen van de produktie van monoclonale antilichamen in vitro door toepassing van een hybridomatechniek, alsmede endotheelcellen en/of supernatant van endotheelcellen.
US4350687A (en) * 1980-02-10 1982-09-21 Research Corporation Platelet derived cell growth factor
US4473552A (en) * 1981-03-16 1984-09-25 Jost Leonora I Anaerobic method for preserving whole blood, tissue and components containing living mammalian cells
US4987079A (en) * 1982-07-06 1991-01-22 Wilbur D. Smith Composition and method for in vitro cell culture
US4520107A (en) * 1982-09-28 1985-05-28 Polydex Chemicals Ltd. Tissue culture and cell growth-promoting material and its method of manufacture
US5045468A (en) * 1986-12-12 1991-09-03 Cell Enterprises, Inc. Protein-free culture medium which promotes hybridoma growth
NO162160C (no) * 1987-01-09 1989-11-15 Medi Cult As Serumfritt vekstmedium, samt anvendelse derav.
US4959308A (en) * 1987-08-27 1990-09-25 Board Of Regents, The University Of Texas System Immunoassay for antibodies binding platelets

Also Published As

Publication number Publication date
DE68916244D1 (de) 1994-07-21
DE68916244T2 (de) 1995-02-09
AU3539289A (en) 1989-11-24
ATE107353T1 (de) 1994-07-15
EP0413727B1 (en) 1994-06-15
JPH03505156A (ja) 1991-11-14
US5198357A (en) 1993-03-30
EP0413727A1 (en) 1991-02-27
WO1989010398A1 (en) 1989-11-02

Similar Documents

Publication Publication Date Title
SE8801537D0 (sv) Cellodlingsmedium samt forfarande for dess framstellning
Jaffe et al. Synthesis of basement membrane collagen by cultured human endothelial cells.
Bentfeld-Barker et al. Identification of primary lysosomes in human megakaryocytes and platelets
Nachman et al. Synthesis of factor VIII antigen by cultured guinea pig megakaryocytes
Huggins et al. Coagulation and liquefaction of semen: proteolytic enzymes and citrate in prostatic fluid
Schlom et al. Detection of high-molecular-weight RNA in particles from human milk
US5318782A (en) Method for preparing tissue repair promoting substances
Pickering et al. The complement system in chronic glomerulonephritis: three newly associated aberrations
Jaffe et al. Subunit structure of factor VIII antigen synthesized by cultured human endothelial cells.
Caulfield et al. The adherence of human neutrophils and eosinophils to schistosomula: evidence for membrane fusion between cells and parasites.
PT97666A (pt) Aparelho para preparar um concentrado de factores de coagulacao a partir de uma amostra de sangue
Stefanini et al. Platelets: VII. Shortened “Platelet Survival Time” and Development of Platelet Agglutinins Following Multiple Platelet Transfusions.
LASZLO et al. The association of thrombotic thrombocytopenic purpura and disseminated lupus erythematosus: report of a case
US4374830A (en) Platelet aggregating material from equine arterial tissue
Pickering The blood plasma in health and disease
Kaenhy et al. Relationship between dialyzer reuse and the presence of anti-N-like antibodies in chronic hemodialysis patients
Rosenfeld et al. The accelerating effect of calcium on the fibrinogen-fibrin transformation
JPS57198867A (en) Non-a, non-b hepatitis related antigen and diagnostic therefor
Parr et al. Primary amyloidosis with plasmacytic dyscrasia and a tetramer of Bence Jones type lambda globulin in the serum and urine
Nour-Eldin et al. The blood clotting factors in human saliva
ATE361975T1 (de) Tiermodell für hepatitis-virus infektion
Harris et al. STUDIES ON THE TRANSFER OF LYMPH NODE CELLS: VIII. The Transfer of Cells from Blood and Peritoneal Exudates Incubated in Vitro with Antigenic Material Derived from Shigella Paradysenteriae
Escolar et al. Interaction of long-term stored platelets with vascular subendothelium
Chong et al. A case of factor V inhibitor
West The estimation of adrenaline in normal rabbit's blood